This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
By This Author:
« Back
Page 1 of 483

Herb Greenberg: What's Next for Valeant After Its Botched Bid for Allergan

By Herb Greenberg

Has the pharmaceutical company really changed its strategy?

09:18AM 12/10/14

Herb Greenberg Says Investors Should Heed the Warnings on Rio Tinto

By Herb Greenberg

When the bearish bet isn't about instant gratification.

10:26AM 12/05/14


Update Ulta, Tibco: Off The Watch List (Reality Check $)

By Herb Greenberg

Two companies come off the list because of improved outlook and a sale.

07:39AM 12/05/14


Invitation to Test Drive All of TheStreet (Reality Check $)

By Herb Greenberg

For only $1, we’ll give you everything we got -- 12 different products -- until the ball drops on New Year’s Eve.

08:26AM 11/26/14


Update Nuance: Careful With Those Headline Numbers (Reality Check $)

By Herb Greenberg

Its stock price notwithstanding.

09:45AM 11/25/14


GameStop: The Digital Divide Growing Wider? (Reality Check $)

By Herb Greenberg

This is moved to a red flag from a yellow.

12:22PM 11/21/14

Greenberg: How Hertz Fooled So Many Hedge Fund Managers

By Herb Greenberg

But suing Audit Integrity wasn't such a good idea.

12:55PM 11/20/14


Update Cyberonics (CYBX) -- Not a Good Quarter (Reality Check $)

By Herb Greenberg

While the medial device company's latest earnings beat expectations, its sales were a disappointment.

11:16AM 11/20/14

« Back
Page 1 of 483

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs